Fresh filings this week reveal a wave of insider selling across US markets. The biggest headline: ASTS founder and CEO Abel Avellan filed on June 23, disclosing a $146.7 million sale. He dumped 2.5 million shares at $58.68 each on June 22. That's a massive disposal by the company's own top executive.
NVDA also drew attention. Director Mark Stevens filed $186 million in total sales on June 23. The trades occurred on June 18 at around $210 per share. NVIDIA's stock has rallied sharply this year, making it a natural profit-taking target.
The Walton family trust sold over $530 million in WMT shares last week. Filings hit on June 18, covering trades on June 16. Routine for the Walton family, but the scale still stands out.
On the buying side, billionaire John Malone filed $7.8 million in fresh purchases of LILA. He bought across two days, June 22 and 23, paying under $6 per share. That's a notable vote of confidence at depressed prices.
Biotech also saw action. KARD director Paul Berns bought $20 million worth of shares on June 22, paying $16 each. That's a rare, high-conviction purchase from a board member.
Meanwhile, power infrastructure firm AGX saw its subsidiary chairman sell over $69 million across three separate filings. Selling at prices between $643 and $760 per share signals ongoing profit-taking after a big run.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
